Matches in SemOpenAlex for { <https://semopenalex.org/work/W2094206874> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2094206874 endingPage "134" @default.
- W2094206874 startingPage "127" @default.
- W2094206874 abstract "The microcystic elongated and fragmented (MELF) pattern of myoinvasion is a feature of some well-differentiated endometrial endometrioid adenocarcinomas that has been associated with poor prognosis. The myoinvasion in MELF-pattern tumors can be subtle and lead to underestimation of the depth of myometrial invasion resulting in tumor understaging; the presence of lymphvascular space invasion (LVSI) and lymph node metastasis in MELF-pattern tumors can also be subtle and lead to tumor understaging. To investigate the association of MELF-pattern invasion and lymph node metastasis, we reviewed a series of well-differentiated endometrioid adenocarcinomas and correlated the presence of MELF-pattern myoinvasion and LVSI with lymph node metastasis. Cases of T1 stage well-differentiated endometrioid adenocarcinomas with LVSI and a concurrent lymph node dissection were identified from departmental files. Hematoxylin and eosin-stained slides from the hysterectomy specimen and lymph nodes were reviewed for the presence of MELF-pattern myoinvasion, LVSI, and nodal metastasis. MELF-pattern myoinvasion was identified at least focally in 36% of cases. The pattern of LVSI differed between cases with MELF-pattern invasion and conventional-type invasion, as did the pattern of nodal metastasis. A statistically significantly higher rate of lymph node metastasis was present in cases with MELF-pattern invasion than in cases with conventional invasion, and the rate stratified with the proportion of MELF-pattern adenocarcinomas. MELF-pattern cases carry an increased rate of lymph node metastasis even within the subset of endometrioid tumors with LVSI, which has implications in routine clinical practice as it signals the importance of recognizing MELF-pattern myoinvasion." @default.
- W2094206874 created "2016-06-24" @default.
- W2094206874 creator A5000521294 @default.
- W2094206874 creator A5002293166 @default.
- W2094206874 creator A5028290642 @default.
- W2094206874 date "2014-03-01" @default.
- W2094206874 modified "2023-10-10" @default.
- W2094206874 title "Lymphovascular Space Invasion in Microcystic Elongated and Fragmented (MELF)-Pattern Well-differentiated Endometrioid Adenocarcinoma is Associated With a Higher Rate of Lymph Node Metastasis" @default.
- W2094206874 cites W2009841878 @default.
- W2094206874 cites W2028017661 @default.
- W2094206874 cites W2044869180 @default.
- W2094206874 cites W2075703167 @default.
- W2094206874 doi "https://doi.org/10.1097/pgp.0b013e318285657b" @default.
- W2094206874 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24487466" @default.
- W2094206874 hasPublicationYear "2014" @default.
- W2094206874 type Work @default.
- W2094206874 sameAs 2094206874 @default.
- W2094206874 citedByCount "53" @default.
- W2094206874 countsByYear W20942068742014 @default.
- W2094206874 countsByYear W20942068742015 @default.
- W2094206874 countsByYear W20942068742016 @default.
- W2094206874 countsByYear W20942068742017 @default.
- W2094206874 countsByYear W20942068742018 @default.
- W2094206874 countsByYear W20942068742019 @default.
- W2094206874 countsByYear W20942068742020 @default.
- W2094206874 countsByYear W20942068742021 @default.
- W2094206874 countsByYear W20942068742022 @default.
- W2094206874 countsByYear W20942068742023 @default.
- W2094206874 crossrefType "journal-article" @default.
- W2094206874 hasAuthorship W2094206874A5000521294 @default.
- W2094206874 hasAuthorship W2094206874A5002293166 @default.
- W2094206874 hasAuthorship W2094206874A5028290642 @default.
- W2094206874 hasConcept C121608353 @default.
- W2094206874 hasConcept C125473707 @default.
- W2094206874 hasConcept C126322002 @default.
- W2094206874 hasConcept C142724271 @default.
- W2094206874 hasConcept C146357865 @default.
- W2094206874 hasConcept C151730666 @default.
- W2094206874 hasConcept C204232928 @default.
- W2094206874 hasConcept C2779013556 @default.
- W2094206874 hasConcept C2779720271 @default.
- W2094206874 hasConcept C2780849966 @default.
- W2094206874 hasConcept C2992571226 @default.
- W2094206874 hasConcept C71924100 @default.
- W2094206874 hasConcept C86803240 @default.
- W2094206874 hasConceptScore W2094206874C121608353 @default.
- W2094206874 hasConceptScore W2094206874C125473707 @default.
- W2094206874 hasConceptScore W2094206874C126322002 @default.
- W2094206874 hasConceptScore W2094206874C142724271 @default.
- W2094206874 hasConceptScore W2094206874C146357865 @default.
- W2094206874 hasConceptScore W2094206874C151730666 @default.
- W2094206874 hasConceptScore W2094206874C204232928 @default.
- W2094206874 hasConceptScore W2094206874C2779013556 @default.
- W2094206874 hasConceptScore W2094206874C2779720271 @default.
- W2094206874 hasConceptScore W2094206874C2780849966 @default.
- W2094206874 hasConceptScore W2094206874C2992571226 @default.
- W2094206874 hasConceptScore W2094206874C71924100 @default.
- W2094206874 hasConceptScore W2094206874C86803240 @default.
- W2094206874 hasIssue "2" @default.
- W2094206874 hasLocation W20942068741 @default.
- W2094206874 hasLocation W20942068742 @default.
- W2094206874 hasOpenAccess W2094206874 @default.
- W2094206874 hasPrimaryLocation W20942068741 @default.
- W2094206874 hasRelatedWork W1998694253 @default.
- W2094206874 hasRelatedWork W2010703875 @default.
- W2094206874 hasRelatedWork W2355691812 @default.
- W2094206874 hasRelatedWork W2381524002 @default.
- W2094206874 hasRelatedWork W2382336308 @default.
- W2094206874 hasRelatedWork W2395525374 @default.
- W2094206874 hasRelatedWork W2884060043 @default.
- W2094206874 hasRelatedWork W3170607289 @default.
- W2094206874 hasRelatedWork W4301944521 @default.
- W2094206874 hasRelatedWork W2113154154 @default.
- W2094206874 hasVolume "33" @default.
- W2094206874 isParatext "false" @default.
- W2094206874 isRetracted "false" @default.
- W2094206874 magId "2094206874" @default.
- W2094206874 workType "article" @default.